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Despite their ready availability for diagnos-
tic study, ecerine sweat glands have not been
reported to show diagnostic anatomic abnor-
mality in any of the known ehromosomal dis-
orders, nor in a large number of genetic dis-
eases. Previous studies in this department have
established the relations of sweat gland duet
length and secretory coil size to sex, age,
height, weight, weight to the two-thirds power,
surface area and calculated total body water of
patients throughout childhood (1). These data
provide a background for investigation of the
anatomy of the ecerine sweat glands in a wide
variety of chromosomal and genetic diseases.
Data demonstrating that these glands are ana-
tomically normal in fibrocystie diseases (cystic
fibrosis of the pancreas) have previously been
published (2). The present study reports the
results of investigation of the anatomy of ec-
crine sweat glands in patients with the clinical
pictures of D1 trisomy (trisomy 13—15), 18
trisomy (E trisomy, trisomy 16—18), and ft
trisomy (trisomy 21, Down syndrome) in com-
parison to patients with Arnold-Chiari malfor-
mation and to a control population. The patients
with Arnold-Chiari malformation (myelomenin-
gocele, hydrocephalus, cerebellar dysplasia, etc.)
were included as a "control" population with
maldevelopment of the central nervous system
not due to chromosomal abnormality.
MATERIALS AND METHODS
Specimens of anterior abdominal skin were ob-
tained at autopsy, and fixed in 10% neutral forma-
lin for at least 7 days (2). Maceration and micro-
dissection were performed by a previously re-
ported method (3).
For each patient, at least ten and not more than
thirty sweat glands were randomly isolated and
then placed in a smooth, thin layer of vasoline on
the bottom of a Petri dish. The measurements of
duet length and coil dimensions were made with
a calibrated ocular micrometer in a dissecting
microscope at magnifications of 30X or 90X (Figs.
4 and 5). Glands with aberrant structure (branch-
ing of the duct, interwoven secretory coils, etc.)
were not measured. A study of these will be made
in a subsequent investigation. The mean sweat
gland duct length (MSGDL) was calculated for
each patient; the product of the coil measure-
ments, called the coil area, was calculated for each
gland and the mean (MCA) derived for each pa-
tient. The ratio of "mean sweat gland duct length"
to "mean coil area", called the sweat gland index(SGI) was also calculated for each patient(MSGDL/MCA = SGI).
Table I summarizes the data on those patients
clinically diagnosed as having one of the three
trisomy syndromes, as well as those with Arnold-
Chiari malformation. Also listed are the cyto-
genetic findings on those patients who had chro-
mosomal studies (white blood cell); all patients
tested were found to be trisomic for the appro-
priate chromosome except for patient S of the 18
trisomy population, who was found to have an
isoehromosome in the E-group. Figure 1 illustrates
graphically the relation of mean sweat gland duet
length to mean coil area for the four groups under
study; for comparison, a control population of
157 patients without specific chromosomal disease
(1), and a series of 36 patients with fibrocystie
disease are also included in the graph (1). Figure
2 presents the sweat gland indices for the same
groups of patients, in relation to the crown-heel
lengths of the patients; height was chosen as the
parameter to be presented because it shows the
closest statistical relation to sweat gland duct
length of the body parameters listed above (1).
Figure 3 presents the data in another form, com-
paring the patients with 18 and D1 trisomy to
control patients with crown-heel length 70 cms or
less, and the C1 trisomy and Arnold-Chiari pa-
tients to controls with crown-heel length 141 ems
or less. Figures 4—7 present representative exam-
ples of eccrine sweat glands of the C1 trisomy, 18
trisomy and control groups.
RE5ULT5
Although the validity of the conclusions is
limited by the fact that only 12 of 49 pa-
tients diagnosed as having one of the three
chromosomal disorders had the diagnosis con-
firmed cytogenetically, the accuracy of clinical
diagnosis of the 18 and ft trisomy syndromes,
at least, would appear adequate for the pur-
poses of this study. With this reservation, the
data presented demonstrate that patients with
G1 trisomy have cccrine sweat glands which
differ from those of controls by having rela-
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TABLE I
G1 trisomy (Down Syndrome, trisomy 21)
Data on populations with chromosomal abnormality, and on the series with Arnold-Chiari malforma-
tion. The specimen from one patient in the G1 trisomy group (,15) was taken in close proximity to a
nipple and the glands are thought to be apocrine.
Case Sex Age Length MSGDL Range MCA Range SGI Cygenetic
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
M
F
M
M
M
M
F
F
F
F
F
F
M
F
M
M
M
F
F
F
M
(Days)
6
8
8
9
60
62
53
12
66
128
112
90
107
212
345
628
660
780
770
2125
3458
(cms.)
40
41
43.5
44
46
47
49
49
50
51
54
54
56.5
60
66
78
79
83
86
103
123
(mm.)
0.7
1.5
1.4
1.0
1.0
1.2
1.9
1.0
1.4
1.3
1.1
1.3
1.3
2.3
1.2
1.5
1.8
1.5
1.7
1.9
2.6
0.6—0.9
1.1—1.8
1.2—1.5
0.9—1.4
0.8—1.1
1.0—1.4
1.4—2.2
0.8—1.2
1.2—1.8
1.0—1.6
0.9—1.2
1.0—1.5
1.0-1.5
1.9—2.8
0.8—1.4
1.0—2.1
1.6—2.3
1.2—1.7
1.5—2.1
1.4—2.4
2.1—3.1
(sq. mm.)
.01
.02
.03
.02
.07
.03
.05
.02
.03
.03
.02
.05
.05
.07
.05
.03
.03
.06
.03
.06
.07
.01—02
.01—.07
.01—05
.01—03
.06—08
.01—08
.01—08
.02—.03
.02—.04
.01—05
.01—04
.03—08
.02—08
.01—11
.04—.08
.02—.08
.01—.04
.03—.08
.01-.04
.03—15
.01—15
70
75
47
50
14
40
38
50
47
43
55
26
26
33
24
50
60
25
57
27
37
Confirmed
Confirmed
Confirmed
Confirmed
Patients
—
Means 1\/SGIL Range (sq.mm.) Range SGI
21 Mean of total
17 Mean of patients not
confirmed
4 Mean of patients confirmed
1.4 .46
1.4 .44
1.4 .61
1.2—1.8
1.2—1.7
1.1—1.8
.04 .018
.04 .017
.04 .028
.02—07
.02—.07
.03—07
43 15.95
44 16.12
37 10.86
D1 trisomy (trisomy 13—15)
Case
1
2
3
4
5
6
7
8
9
10
Sex
F
F
F
M
M
M
M
M
M
F
Age
(Days)
1
9
7
21
135
3
8
2
24
77
Length
(ems.)
42
42.5
46
46
47
49
50
50
51
52
MSDGL
(mm.)
1.1
0.7
0.9
1.3
0.7
1.3
1.0
0.9
0.7
0.7
Range
0.8—1.2
0.6—1.0
0.8-1.3
0.9—1.4
0.6—0.8
1.1—1.6
0.7—1.3
0.8—1.1
0.6—0.8
0.5—0.9
MCA
(sq. mm.)
.05
.02
.02
.07
.03
.05
.04
.04
.03
.03
Range
.02—06
.01—05
.01—03
.04—.12
.01—03
.02—.06
.01—.04
.02—06
.01—.04
.01—.04
SGI
22
40
45
19
23
26
29
23
35
23
Cytogenetic
Confirmed
Patients Means MSGDL Range (sq.mm.) Range SGI
10
9
1
Mean of total
Mean of patients not
confirmed
Mean of patients confirmed
0.9 .24
0.9 .22
1.3
0.6—1.1
0.7—1.7
0.9—1.4
.04 .014
.03 .012
.07
.02—.07
.01—05
.04—12
29 8.69
30 8.49
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TABLE I—Continugd
18 trisomy (E trisomy)
Case Sex Age Length MSGDL Range MCA Range SGI Cytogenetic
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
F
F
F
M
F
M
F
F
F
F
F
F
F
F
F
F
M
F
(Days)
3
11
60
15
26
2
21
60
424
2
97
35
18
60
57
32
76
910
(ems.)
42
43
44
44
45
46
47
47
47
47
48
49
49
50
50
51
54
68
(mm.)
1.1
0.9
1.4
0.9
1.0
0.7
1.0
1.0
1.0
1.4
1.1
1.4
1.1
1.1
0.8
1.0
1.3
1.1
1.0—1.4
0.8—1.1
1.2-1.7
0.8—1.1
0.8—1 .2
0.6—0.9
0.9—1.1
0.9-1.2
0.9-1.2
1.2—1.5
1.0—1.3
1.2—1.7
1.0—1.2
0.9—1.3
0.75—.95
0.8—1.1
1.0-1.5
0.9-1.3
(sq. mm.)
.04
.03
.06
.04
.03
.02
.04
.02
.04
.05
.05
.06
.06
.05
.04
.04
.07
.04
.02—05
.02—05
.03—09
.02—07
. 02—.04
.01—04
.03—06
.01—06
.03—.06
.04—OS
.02—09
.03—09
.03—09
.O3—.08
.01—06
.01—06
.04-.10
.03—07
28
30
23
23
33
35
25
50
25
28
25
23
18
22
20
25
19
28
Confirmed
Confirmed
Confirmed
Confirmed
Confirmed
Confirmed
Confirmed
Patients Means
18 Mean of total
11 Mean of patients not
confirmed
7 Mean of patients confirmed
1v,1 Range (sq.mm.) Range SGI
1.1 .20
1.1 .23
1.0 .11
0.9—1.3
1.0—1.3
0.9—1.2
.04 .014
.05 .015
.04 .012
.02—.07
.03—07
.02—07
27 8.41
26 4.36
28 3.42
Arnold-dhiari Malformation
Case Sex Age Length MSGDL Range MCA Range SGI Cytenetic
1
2
3
4
5
6
7
8
9
10
11
M
F
F
F
F
M
F
F
M
M
M
(Days)
2
25
12
8
74
34
120
212
730
2675
4745
(ems.)
44
44
46
48
54
54
58
65
75
116
141
(mm.)
1.0
1.3
1.0
1.2
1.0
1.2
1.2
1.4
1.2
1.5
1.8
0.8—1.1
1.1—1.5
0.9—1.0
1.0—1.4
0.9—1.2
1.0—1.5
0.9—1.5
1.1—1.6
0.9—1.5
1.3—1.8
1.6—2.1
(sq. mm.)
.03
.04
.02
.05
.04
.04
.04
.04
.04
.08
.09
.02—05
.01—08
.01-04
.04—07
.02—08
.02-.05
.02—.06
.02—.06
.01—05
.05—15
.05—13
33
33
50
27
25
30
30
35
30
19
20
Patients Means
11 Mean of total
iVSGDL Range (sq. mm.) Range SGI
1.3 .25 1.0—1.5 .05 .020 .02—07 30 10.14
tively long excretory ducts in relation to the
size of their secretory coils (a large sweat gland
index). Similarly, patients with 18 trisomy
have glands which differ from normal by hav-
ing short ducts in relation to the size of the
secretory coils (small sweat gland index). Pa-
tients with D1 trisomy do not apparently dif-
fer from the control population, although the
number of cytogenetically confirmed patients in
this group is too small for reliable conclusions.
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TABLE II
Statistical summary of the four populations
of Table I compared to the control population.
The chi square values given are not based on
Yates' correction.
1. Patients with crown-heel length 55 cms. or less.
SGI above 35 SGI 35 or less
Trisomy G1 10
Trisomy D1 2
Controls 19
2
8
23
x2, trisomy G1 vs. controls = 6.67 (SGI of
trisomy 21 large).
x2, trisomy D1 vs. controls = not significant
at any level.
x2, trisomy D1 vs. Arnold-Chiari malforma-
tion = not significant at any level.
tvalue, trisomy D1 vs. controls = 1.32 (p > .05).
2. Patients with crown-heel length 70 ems. or less.
SGI above 30 SGI 30 or less
Trisomy 18
Controls
Arnold-Chiari
3
43
6
15
23
2
x2, trisomy 18 vs. controls = 13.4 (SGI of
trisomy 18 small).
x2, trisomy 18 vs. Arnold-Chiari malforma-
tion = 8.36 (SOT of trisomy 18 small).
value, trisomy 18 vs. controls = 2.26 (p < .05).
SGI above 35 SGI 35 or less
Trisomy G1 10 5
Arnold-Chiari mal- 1 7
formation
x5, trisomy G1 vs. Arnold-Chiari malforma-
tion = 6.11 (SGI of trisomy 21 large).
SGI above 45 SGI 45 or less
Trisomy G1 7 8
Controls 10 56
Trisomy 18 1 17
x2, trisomy G1 vs. controls = 7.24 (SGI of
trisomy G1 large).
x2, trisomy G1 vs. trisomy 18 = 7.51 (SGT of
trisomy G1 large).
x2, Arnold-Chiari malformation vs. normals =
not significant at any level.
3. Patients with crown-heel length 145 ems, or
less.
SGI above 35 SGI 35 or less
Trisomy G1
Arnold-Chiari mal-
formation
Controls
14
1
38
7
10
98
x2, trisomy G1 vs. controls = 12.3 (SGI of
trisomy G1 large).
x2, trisomy G1 vs. Arnold-Chiari malforma-
tion 9.58 (SGI of trisomy G1 large).
x2, Arnold-Chiari malformation vs. controls =
not significant at any level.
tvalue, trisomyGivs. controls = 3.91 (p < .01).
value, Arnold-Chiari malformation vs. con-
trols = 0.25 (no significance).
E
E
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-J
1
-J
Ui
1
AX
Ui
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MEAN COIL AREA IN mm2
IFie. 1. Relation of mean sweat gland duct length to mean coil area for patients with G1
trisomy, D1 trisomy, 18 trisomy, and Arnold-Chiari malformation. Black dots indicate con-
trol patients, and circles indicate patients with fibrocystic disease. The dotted triangle in-
dicates the patient with Down syndrome whose skin specimen probably contained apocrine
rather than eccrine glands.
30 40 50 60 70 80 90 100 110 20 130 140 150 160 170 180
HEIGHT IN cm.
Fie. 2. Relation of sweat gland index (MSGDL/MCA), to crown-heel length for the
same populations as Fig. 1.
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Patients with Arnold-Chiari complex or fibro- show maldevelopment of the central nervous
cystic disease also do not differ from the control system, and that patients with Arnold-Chiari
population. The facts that all three populations malformation have normal sweat gland anat-
considered to have chromosomal abnormality omy, indicate that the abnormal sweat glands
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of the patients considered to have G1 trisomy
and 18 trisomy are not due simply to cerebral
maldevelopment, but reflect in some more spe-
cific way the abnormal gene balance produced
by the chromosomal abnormality. Whether the
anatomic abnormality of the eccrine glands of
patients with G1 and 18 trisomy is reflected in
abnormal chemical composition of their sweat,
and whether either the anatomic findings or any
possible biochemical counterparts have practical
diagnostic value, remain to be determined.
SUMMAnY
The duct length, secretory coil size, and the
ratio of the two, were determined by measure-
ment of microdissected eccrine sweat glands
from series of patients clinically diagnosed as
having the D1, 18 and G1 trisomy syndromes
(trisomy 13—15, trisomy 16—18, and the Down
syndrome). The findings were compared to
those of a series of patients with Arnold-Chiari
malformation, a developmental disorder of the
central nervous system, and to a control popu-
laton. With the reservation that only 12 of 49
patients clinically diagnosed as having one of
the three chromosomal disorders were con-
firmed cytogenetically, patients with G1 trisomy
were found to have eccrine sweat glands with
long excretory ducts relative to the size of the
secretory coils, and patients with 18 trisomy
the reverse relation. The patients diagnosed as
.
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FiG. 3. Comparison of sweat gland indices of the abnormal populations of Fig. 1 to con-
trol populations of differing size. The circled star in the G1 trisomy column indicates the
patient whose specimen is thought to contain apocrine glands.
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Fie. 4. Representative eeerine sweat gland from
a patient with ft trisomy (7). The gland is
mounted on a hemoeytorneter, and stained with
Mallory's iron hematoxyhn. (X100). The arrows
indicate the length of the duet segment measured.
FIG. 5. Coil of ecerine gland from the same pa-
tient as fig. 4. The arrows indicate the dimensions
of the seeretery coil measured. Preparation as in
Fig. 4. (X100).
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Fie. 6. Representative eeerine sweat gland from
a patient with 18 trisomy (8). Preparation as in
Fig.4. (X100).
FIG. 7. Representative eeerine sweat gland from
a control patient with crown-heel length of 50
ems. Preparation as in Fig. 4. (X100).
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having D1 trisomy, and those with the Ar- glands. The Physiology oJ Growth & Body
Composition. Eds., Cheek, D., at al., In press.nold-Chiari malformation had anatomically nor- 2. Bartman, J. and Landing, B. H.: Morphology of
mal eecrine sweat glands. the sweat apparatus in cystic fibrosis. Am. J.
Clin. Path., 45: 455, 1966.REFERENCES 3. Wells, T. R.: A rapid method of maceration for
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